21/11/2026, Saturday15:52

Menu

EDITION   :

TRTRENENARARFRFRRURUURUR

Notifications

You have no new notificationsHome
Turkish Aerospace Industries CEO Mehmet Demiroglu said Spain plans to purchase 15 additional Hurjet trainer aircraft after signing a deal for 30 of the Turkish-made supersonic jets, with deliveries to the European nation scheduled to begin in 2028.ASELSAN announced that its GOKALP Counter-UAV System successfully destroyed a target drone using a hit-to-kill interceptor during a live demonstration at the company's Ogulbey Technology Base, marking the entry of a fully mobile and cost-effective solution into Türkiye's autonomous air defense portfolio.President Recep Tayyip Erdogan on Friday criticized the existing global order and the United Nations, warning that binding international accords and judicial rulings are increasingly ignored while the UN system lacks legitimacy for failing to reflect the will of the global community.Foreign Minister Hakan Fidan said Thursday that Ankara has finalized preparations to submit the Mecca defense agreement to parliament for approval, stressing that the pact provides for mutual defense and does not authorize attacks or troop deployments to other countries.The Royal Swedish Academy of Sciences on Wednesday awarded the 2026 Nobel Prize in Chemistry to Henri Kagan and Kenso Soai for discoveries explaining how molecular asymmetry essential to life emerges through autocatalysis, resolving a century-old mystery about homochirality with significant implications for drug development.

Three major pharmaceutical companies are estimated to make a total of around $32 billion in revenue from their COVID-19 vaccines next year, according to a report on Monday.

US pharmaceutical firm Pfizer is expected to generate $19 billion revenue from the vaccine in 2021, American multinational investment bank and financial services company Morgan Stanley said in its report.

Pfizer will split its revenues from vaccine sales with its German partner BioNTech.

While Pfizer is projected to have $975 million in vaccine revenue this year alone, the report said it is estimated to have $9.3 billion combined revenue in 2022 and 2023 as the world would continue to get vaccinated.

Moderna, the other US pharmaceutical firm that managed to invent and manufacture its own vaccine, is expected to make $13.2 billion from vaccine sales in 2021.

The firm is also estimated to make somewhere between $10 billion to $15 billion additional revenue from its COVID-19 vaccine in 2021 and 2022, according to projections.

Since the beginning of the pandemic, around 72.3 million have contracted the novel coronavirus and more than 1.6 million people have lost their lives, according to latest data from US-based Johns Hopkins University.

Comments

Comments you share on our site are a valuable resource for other users. Please be respectful of different opinions and other users. Avoid using rude, aggressive, derogatory, or discriminatory language.